Karnataka HC Permits Transwomen to Continue Hormone Therapy Pending Challenge to Transgender Amendment Act

The Karnataka High Court passed an interim order permitting transwomen to continue their hormone replacement therapy while a constitutional challenge to the Transgender Persons (Protection of Rights) Amendment Act remains pending. The order reflects the Court's recognition that abruptly discontinuing medically supervised hormone therapy poses serious health risks and that the right to healthcare and bodily autonomy cannot be suspended merely because the underlying legislation is under judicial review. The case is part of a broader set of challenges to recent amendments to the Transgender Persons (Protection of Rights) Act, 2019 that have raised concerns within the transgender community.

The Transgender Persons Act 2019 and Recent Amendments

The Transgender Persons (Protection of Rights) Act, 2019 was enacted to provide legal recognition to transgender persons and to prohibit discrimination in education, employment, and healthcare. The Act established a process for obtaining a certificate of identity reflecting a person's self-identified gender, and it created obligations on the government to provide welfare measures, including healthcare facilities. However, the Act faced criticism from the transgender community for not fully aligning with the principles laid down by the Supreme Court in NALSA v. Union of India (2014), particularly regarding the right to self-identification of gender without medical intervention. Recent amendments to the Act have further complicated the regulatory landscape, introducing provisions that some advocates argue impose additional bureaucratic requirements on transgender persons seeking to access healthcare, including hormone therapy and gender-affirming procedures.

The Healthcare Dimension: Why Continuity Matters

Hormone replacement therapy for transgender persons is not a cosmetic procedure but a medically supervised treatment that, once initiated, requires ongoing administration. Abrupt cessation of hormone therapy can cause significant physical and psychological harm, including hormonal imbalances, bone density loss, cardiovascular complications, and severe mental health consequences such as depression and anxiety. Medical guidelines from endocrinology associations worldwide emphasise that hormone therapy for transgender individuals should be maintained consistently under medical supervision. The petitioners before the Karnataka High Court presented medical evidence establishing that discontinuing therapy would pose immediate and serious health risks, making the question of interim relief a matter of personal health and safety rather than merely a legal technicality.

The Karnataka High Court's Interim Order

The Karnataka High Court, applying the standard three-part test for interim relief (prima facie case, balance of convenience, and irreparable harm), found that all three elements weighed in favour of the petitioners. On the prima facie case, the Court noted that the constitutional challenge raised serious questions about whether the amendments were consistent with the fundamental rights guaranteed under Articles 14, 15, 19, and 21 of the Constitution, as interpreted in NALSA v. Union of India. On the balance of convenience, the Court observed that permitting individuals to continue existing medical treatment while the challenge is heard does not prejudice the government's position, whereas preventing treatment could cause serious harm. On irreparable harm, the medical evidence presented was clear that discontinuation of hormone therapy could result in health consequences that would be difficult or impossible to reverse.

Constitutional Context: NALSA and the Right to Gender Identity

The Supreme Court's landmark decision in National Legal Services Authority v. Union of India (2014) recognised the right of transgender persons to self-identify their gender as part of their fundamental right to personal autonomy and dignity under Article 21. The Court directed the central and state governments to provide legal recognition to transgender persons in their self-identified gender, to take steps to ensure their fundamental rights, and to extend welfare benefits. The NALSA judgment has served as the constitutional baseline against which all subsequent legislation and regulation affecting transgender persons is evaluated. The challenge to the amendments before the Karnataka High Court draws heavily on NALSA, arguing that any regulatory framework that creates barriers to accessing gender-affirming healthcare effectively undermines the rights that NALSA recognised.

Key Takeaways

The Karnataka High Court's interim order is a significant protective measure for transgender persons currently undergoing hormone therapy. It establishes that the right to continue medically necessary treatment cannot be disrupted by legislative changes that are themselves under constitutional challenge. The case will be closely watched as it proceeds to a final hearing, where the Court will determine whether the amendments to the Transgender Persons Act are constitutionally valid. For the transgender community and healthcare providers, the interim order provides reassurance that existing treatment regimens can continue uninterrupted while the legal questions are resolved. The outcome of the constitutional challenge will have implications for transgender rights across India.